38696 Federal Register / Vol. 82, No. 156 / Tuesday, August 15, 2017 / Notices 

ADUFA/ucm042896.htm or in this 

docket at https://www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Sujaya Dessai, Center for Veterinary 

Medicine (HFV–212), Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 240–402–5671, 

sujaya.dessai@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Animal 

drug sponsors are required to report 

annually to FDA the amount of 

antimicrobials sold or distributed for 

use in food-producing animals and 

provide species-specific estimates of the 

percentage of their drug product sales 

for use in any of the four major foodproducing species (cattle, swine, 

chickens, and turkeys) identified on the 

approved product label (21 CFR 

514.87(c)). FDA is announcing the 

availability of a proposed method for 

using a biomass denominator to adjust 

these sales data. The proposed method 

will provide estimates of annual 

antimicrobial drug sales adjusted for the 

size of the animal population (the 

animal biomass of each such species) 

potentially being treated with those 

drugs. The adjusted estimates will 

provide insight into broad shifts in the 

amount of antimicrobials sold for use in 

food-producing animals and give the 

Agency a more nuanced view of why 

sales increase or decrease over time in 

a manner that is specific to U.S. animal 

production. Such analysis will also 

support our ongoing efforts to encourage 

the judicious use of antimicrobials in 

food-producing animals to help ensure 

the continued availability of safe and 

effective antimicrobials for animals and 

humans. 

Application of a biomass denominator 

to normalize antimicrobial sales data 

has been used internationally. In 

developing this proposal for applying a 

biomass denominator to antimicrobial 

sales data in the United States, FDA has 

considered methods being utilized and 

discussed in other countries. FDA’s 

intent in publishing the proposed 

method is to initiate discussion with 

stakeholders on the biomass correction 

method FDA is considering, and to seek 

comment on the methodology and the 

utility of this type of data analysis. 

Dated: August 10, 2017. 

Anna K. Abram, 

Deputy Commissioner for Policy, Planning, 

Legislation, and Analysis. 

[FR Doc. 2017–17206 Filed 8–14–17; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Alzheimer’s 

Disease Drug Development. 

Date: September 15, 2017. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway, Suite 2W200, 7201 Wisconsin Ave., 

Bethesda, MD 20892 (Telephone Conference 

Call). 

Contact Person: Alexander Parsadanian, 

Ph.D., Scientific Review Officer, National 

Institute on Aging, Gateway Building 2C/212, 

7201 Wisconsin Avenue, Bethesda, MD 

20892, 301–496–9666, parsadaniana@

nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; AD 

Sequencing Project Data Analysis. 

Date: September 20, 2017. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway, Suite 2W200, 7201 Wisconsin Ave., 

Bethesda, MD 20892 (Telephone Conference 

Call). 

Contact Person: Alexander Parsadanian, 

Ph.D., Scientific Review Officer, National 

Institute on Aging, Gateway Building 2C/212, 

7201 Wisconsin Avenue, Bethesda, MD 

20892, 301–496–9666, parsadaniana@

nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: August 8, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–17155 Filed 8–14–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Environmental 

Health Sciences; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Environmental Health 

Sciences Review Committee. 

Date: August 29–30, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Imperial Hotel and 

Convention Center, 4700 Emperor Boulevard, 

Durham, NC 27703. 

Contact Person: Linda K. Bass, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research and 

Training, Nat’l Institute of Environmental 

Health Sciences, P.O. Box 12233, MD EC–30, 

Research Triangle Park, NC 27709, (919) 541– 

1307. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Environmental Health Sciences Special 

Emphasis Panel; 1 P30 Core Center Conflict 

Review. 

Date: August 30, 2017. 

Time: 2:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Imperial Hotel and 

Convention Center, 4700 Emperor Boulevard, 

Durham, NC 27703. 

Contact Person: Leroy Worth, Ph.D., 

Scientific Review Officer Scientific Review 

Branch, Division of Extramural Research and 

Training, Nat. Institute of Environmental 

Health Sciences, P.O. Box 12233, MD EC–30/ 

Room 3171, Research Triangle Park, NC 

27709, 919/541–0670, worth@niehs.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

mstockstill on DSK30JT082PROD with NOTICES